Cite
The structural conformation of the tachykinin domain drives the anti-tumoural activity of an octopus peptide in melanoma BRAFV600E.
MLA
Moral, Sanz, Javier, et al. “The Structural Conformation of the Tachykinin Domain Drives the Anti-Tumoural Activity of an Octopus Peptide in Melanoma BRAFV600E.” British Journal of Pharmacology, vol. 179, no. 20, Oct. 2022, pp. 4878–96. EBSCOhost, https://doi.org/10.1111/bph.15923.
APA
Moral, S. J., Fernandez, R. M. A., Colmenarejo, G., Kurdyukov, S., Brust, A., Ragnarsson, L., Andersson, Å., Vila, S. F., Cabezas, S. P., Wilhelm, P., Vela, S. A., Fernández, C. I., Chin, Y. K. Y., López, M. Y., Smallwood, T. B., Clark, R. J., Fry, B. G., King, G. F., Ramm, G. A., & Alewood, P. F. (2022). The structural conformation of the tachykinin domain drives the anti-tumoural activity of an octopus peptide in melanoma BRAFV600E. British Journal of Pharmacology, 179(20), 4878–4896. https://doi.org/10.1111/bph.15923
Chicago
Moral, Sanz, Javier, Rojo, Manuel A. Fernandez, Gonzalo Colmenarejo, Sergey Kurdyukov, Andreas Brust, Lotten Ragnarsson, Åsa Andersson, et al. 2022. “The Structural Conformation of the Tachykinin Domain Drives the Anti-Tumoural Activity of an Octopus Peptide in Melanoma BRAFV600E.” British Journal of Pharmacology 179 (20): 4878–96. doi:10.1111/bph.15923.